Ontology highlight
ABSTRACT:
SUBMITTER: Vernieri C
PROVIDER: S-EPMC7139362 | biostudies-literature | 2020 Mar
REPOSITORIES: biostudies-literature
Vernieri Claudio C Prisciandaro Michele M Nichetti Federico F Lobefaro Riccardo R Peverelli Giorgia G Ligorio Francesca F Zattarin Emma E Cona Maria Silvia MS Sepe Pierangela P Corti Francesca F Manglaviti Sara S Brambilla Marta M Re Barbara B Belfiore Antonino A Pruneri Giancarlo G Celio Luigi L Mariani Gabriella G Bianchi Giulia Valeria GV Rivoltini Licia L Capri Giuseppe G de Braud Filippo F
Cancers 20200306 3
<i>Background</i>: Single-agent capecitabine (C) is a moderately effective chemotherapeutic compound in the treatment of patients with HER2-negative metastatic breast cancer (mBC). The capecitabine-vinorelbine (CV) combination is also used due to a good tolerability profile, but no studies have demonstrated its superiority over single-agent C. <i>Methods</i>: We conducted a retrospective analysis to compare overall response rate (ORR), progression-free survival (PFS), overall survival (OS) and i ...[more]